Skip to main content
Premium Trial:

Request an Annual Quote

Bankruptcy Court Approves True Health Dx's $37.1M Bid for HDL's Assets

NEW YORK(GenomeWeb) – Health Diagnostic Laboratory announced late on Wednesday that a US Bankruptcy Court judge has approved the $37.1 million sale of substantially all of the firm's assets to True Health Diagnostics. 

The deal is anticipated to be completed by the end of the month. Frisco, Texas-based True Health outbid other firms for HDL's assets in an auction held last week after increasing its initial stalking horse bid of $32 million made earlier this month.

Richmond, Virginia-based HDL filed for Chapter 11 protection in June shortly after reaching an agreement with the US Department of Justice to settle an investigation into whether HDL's payments to doctors were essentially kickbacks to encourage them to order the firm's tests. HDL agreed to pay nearly $50 million as part of the settlement but denied wrongdoing. 

True Health CEO Chris Grottenthaler said in a statement on Tuesday that the firm will adopt "an exacting corporate compliance program that, along with rigorous controls and intensive sales force training, will ensure that True Health will meet and exceed all regulatory requirements."

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.